课题基金 / 基金详情

ROLE OF CD46 IN MEASLES ENTRY AND IMMUNOSUPPRESSION

ROLE OF CD46 IN MEASLES ENTRY AND IMMUNOSUPPRESSION
CD46 在麻疹进入和免疫抑制中的作用
批准号:
6752053
负责人:
MARIANNE MANCHESTER
金额:
$31.06万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-08-01 至 2006-05-31

项目摘要

项目成果

MARIANNE MANCHESTER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from the Investigator's abstract): Despite an effective vaccine, measles virus (MV) is still the seventh leading cause of death worldwide. MV causes significant morbidity an mortality due to virus-associated immunosuppression and kills over 1 million children per year. Why is measles still a public health problem when a vaccine is available? The extremely infectious nature of the virus interference with MV vaccination by maternally-acquired antibodies, and waning immunity in vaccines all contribute to the stubborn resistance of MV to eradication. The interaction between viruses and cell-surface receptors is a major determinant of virus tropism an pathogenesis. For MV, the cell-surface receptor has been identified as the complement receptor CD46. The normal function of CD46 is to bind complement components on the cell surface and prevent their deposition on host cells. Previous studies have shown that complement C3b, the primary ligand for CD46 interacts with regions of the extracellular domain of CD46 near the membrane. Laboratory strains of MV, in contrast, interact with the N-terminal third of the extracellular domain of CD46. This interaction not only results in MV attachment and entry, but can also signal target lymphocytes to downregulate cytokine production. The long range goal of this project, is to determine how wild-type MV interacts with the MV receptor CD46 to result in host-cell attachment, entry and modulation on intracellular signaling. First, emphasis is placed on mapping the specific interaction between wild-type strains of MV and the extracellular domain of the CD46 receptor. A combined molecular genetic and structural analysis will be used to identify and characterize the domain of the CD46 receptor that are responsible for interacting with wild-type MV to achieve virus binding, entry an immunosuppressive effects in target host cells. A second emphasis of this grant is to characterize the signaling events that occur upon liganding of CD46 by wild-type and laboratory strains of MV and how these events regulate virus entry and immune function. Determining how the interaction between MV and CD46 influences intracellular signals is important not only for understanding how measles-induced immunosuppression occurs, but provides a potential tool for studying how virus-receptor interactions can modulate host cell functions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multivalent VAccines for Biodefense
  • 批准号:
    7849969
  • 项目类别:
  • 资助金额:
    $26.11万
  • 财政年份:
    2009
  • 负责人:
    MARIANNE MANCHESTER
  • 依托单位:
Multivalent VAccines for Biodefense
  • 批准号:
    7739980
  • 项目类别:
  • 资助金额:
    $26.11万
  • 财政年份:
    2009
  • 负责人:
    MARIANNE MANCHESTER
  • 依托单位:
Receptor Decoy Inhibitor of Anthrax Toxin
Receptor Decoy Inhibitor of Anthrax Toxin
海外基金